Advances in gene chip technique in Barrett's metaplasia and adenocarcinoma

Journal of Digestive Diseases

Volumn 9, Issue 2, 2008, Pages 68-71

  Wang, Xing Wei ^a   Gao, Heng Jun ^b   Fang, Dian Chun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b NATIONAL ENGINEERING CENTER FOR BIOCHIP AT SHANGHAI   (China)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; Gene chip; Genetic expression; Microarray

Indexed keywords

APC PROTEIN; BETA CATENIN; BIOLOGICAL MARKER; CADHERIN; CATENIN; COMPLEMENTARY DNA; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIC AMP BINDING PROTEIN; CYCLIN D1; CYCLOOXYGENASE 2; DEATH ASSOCIATED PROTEIN KINASE; ENDOGLIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; MATRILYSIN; PROTEIN BCL 2; PROTEIN P16; PROTEIN P53; STROMELYSIN; TRANSFORMING GROWTH FACTOR ALPHA; UVOMORULIN;

BARRETT ESOPHAGUS; CANCER RECURRENCE; CANCER STAGING; CARCINOGENESIS; DNA MICROARRAY; DRUG TARGETING; ESOPHAGEAL ADENOCARCINOMA; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; MALIGNANT TRANSFORMATION; MEDICAL DECISION MAKING; MICROARRAY ANALYSIS; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN MICROARRAY; REVIEW; TH1 CELL; TH2 CELL;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METAPLASIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 42449157626     PISSN: 17512972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2008.00324.x     Document Type: Review

References (18)

1. Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol 2005; 162 (11): 1050-61.
2. Deviere J. Barrett's oesophagus: The new endoscopic modalities have a future. Gut 2005; 54: 33-7.
3. Yan X, Selaru FM, Jing Y et al. Artificial neural networks gene filtering distinguish between global gene expression profiles Barrett's esophagus esophageal cancer. Cancer Res 2002; 62: 3493-7.
4. Lagarde SM, ten Kate FJ, Richel DJ et al. Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol 2007; 14: 977-91.
5. Flejou JF. Barrett's oesophagus. From metaplasia to dysplasia and cancer. Gut 2005; 54: 6-12.
6. Morales CP, Souza RF, Spechler SJ. Hallmarks of cancer progression in Barrett's oesophagus. Lancet 2002; 36: 1587-9.
7. Lagarde SM, ten Kate FJ, Richel DJ et al. Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol 2007; 14: 977-81.
8. Greenawalt DM, Duong C, Smyth GK et al. Gene expression profiling of esophageal cancer: Comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma. Int J Cancer 2007; 120: 1914-21.
9. Hao Y, Sood S. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure. BMC Gastroenterol 2007; 7: 1471-7.
10. Montgomery E, Mamelak AJ, Gibson M et al. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions. Appl Immunohistochem Mol Morphol 2006; 14: 24-30.
11. Wang S, Zhan M, Yin J et al. Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. Oncogene 2006; 25: 3346-56.
12. El-Serag H-B, Nurgalieva Z, Souza R-F et al. Is genomic evaluation feasible in endoscopic studies of Barrett's esophagus? A pilot study. Gastrointest Endosc 2006; 64: 17-26.
13. Miller CT, Lin L, Casper AM et al. Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 2006; 25: 409-18.
14. Siersema PD. Pathogenesis, diagnosis and therapeutic possibilities of esophageal cancer. Curr Opin Gastroenterol 2007; 23: 456-61.
15. Kuester D, Dar AA, Moskaluk CC et al. Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression. Neoplasia 2007; 9: 236-45.
16. Brabender J, Marjoram P, Salonga D et al. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. Oncogene 2004; 23: 4780-8.
17. Cheng P, Gong J, Wang T et al. Gene expression in rats with Barrett's esophagus and esophageal adenocarcinoma induced by gastroduodenoesophageal reflux. World J Gastroenterol 2005; 11: 5117-22.
18. Helm J, Enkemann SA, Coppola D et al. Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Clin Cancer Res 2005; 11: 2478-85.